Jason W. Myers
Vorstandsvorsitzender bei GenapSys, Inc.
Profil
Jason W.
Myers is the founder of ArcherDX LLC, which was founded in 2013.
He held the titles of President, Chief Executive Officer & Director from 2015 to 2020.
Dr. Myers is currently the Chief Executive Officer & Director at Sequencing Health, the Chief Executive & Financial Officer, Director at GenapSys, Inc., and the Director at Venn Biosciences Corp.
Dr. Myers's former jobs include Director at Invitae Corp.
from 2020 to 2021, Independent Director at IsoPlexis Corp.
from 2021 to 2023, and Chief Scientific Officer at Universal Display Corp.
from 2013 to 2015.
He also held the title of Chief Scientific Officer at QIAGEN Beverly LLC.
Dr. Myers's education includes an undergraduate degree from Colorado State University and a doctorate from Stanford University School of Medicine.
Aktive Positionen von Jason W. Myers
| Unternehmen | Position | Beginn |
|---|---|---|
GenapSys, Inc.
 GenapSys, Inc. Miscellaneous Commercial ServicesCommercial Services GenapSys, Inc. develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing. It also develops gene electronic nano-integrated ultra-sensitive platform device for chip-based DNA sequencing. The company was founded by Hesaam Esfandyarpour in 2010 and is headquartered in Redwood, CA. | Vorstandsvorsitzender | 15.02.2021 |
Venn Biosciences Corp.
 Venn Biosciences Corp. BiotechnologyHealth Technology Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA. | Direktor/Vorstandsmitglied | 04.10.2022 |
Sequencing Health
 Sequencing Health Miscellaneous Commercial ServicesCommercial Services Sequencing Health develops DNA sequencing technology. The private company is based in Atlanta, GA and has subsidiaries in the United States. The CEO of the company is Jason W. Myers. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Jason W. Myers
| Unternehmen | Position | Ende |
|---|---|---|
| ISOPLEXIS CORPORATION | Direktor/Vorstandsmitglied | 21.03.2023 |
| INVITAE CORPORATION | Direktor/Vorstandsmitglied | 05.07.2021 |
ArcherDX LLC
 ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Gründer | 02.10.2020 |
| UNIVERSAL DISPLAY CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 |
QIAGEN Beverly LLC
 QIAGEN Beverly LLC BiotechnologyHealth Technology Qiagen Beverly, Inc. produces reagents, kits and assays enables customers worldwide to transform patient treatment and life science research. Its products include xmal, mapl, taqiT, wgs ligase, sall, xhol and bamhi. The company was founded by Christopher Benoit and Stephen Picone in 2006 and is headquartered in Beverly, M A. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jason W. Myers
| Colorado State University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| UNIVERSAL DISPLAY CORPORATION | Electronic Technology |
| INVITAE CORPORATION | Health Services |
| Private Unternehmen | 6 |
|---|---|
QIAGEN Beverly LLC
QIAGEN Beverly LLC BiotechnologyHealth Technology Qiagen Beverly, Inc. produces reagents, kits and assays enables customers worldwide to transform patient treatment and life science research. Its products include xmal, mapl, taqiT, wgs ligase, sall, xhol and bamhi. The company was founded by Christopher Benoit and Stephen Picone in 2006 and is headquartered in Beverly, M A. | Health Technology |
GenapSys, Inc.
GenapSys, Inc. Miscellaneous Commercial ServicesCommercial Services GenapSys, Inc. develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing. It also develops gene electronic nano-integrated ultra-sensitive platform device for chip-based DNA sequencing. The company was founded by Hesaam Esfandyarpour in 2010 and is headquartered in Redwood, CA. | Commercial Services |
IsoPlexis Corp.
 IsoPlexis Corp. Packaged SoftwareTechnology Services IsoPlexis Corp. engages in the development of curative medicines and personalized therapeutics. Its single cell proteomics platform, which includes instruments, chip consumables and software, provides an end-to-end solution to reveal a more complete view of protein function at an individual cellular level. The company was founded by Sean Mackay, Rong Fan, and Kara K. Brower in March 2013 and is headquartered in Branford, CT. | Technology Services |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Technology Services |
Venn Biosciences Corp.
Venn Biosciences Corp. BiotechnologyHealth Technology Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA. | Health Technology |
Sequencing Health
Sequencing Health Miscellaneous Commercial ServicesCommercial Services Sequencing Health develops DNA sequencing technology. The private company is based in Atlanta, GA and has subsidiaries in the United States. The CEO of the company is Jason W. Myers. | Commercial Services |
